Nicole Couture

Statistics

Publications

Citations

270

H-Index

Active since

1998

Affiliations

Massachusetts General Hospital(Current)

Dana-Farber Cancer Institute

Harvard University

Harvard University Press

Emory University

Nicole Couture is an author at Massachusetts General Hospital specializing in multiple myeloma treatment, hematologic malignancy therapy, and hematologic malignancy pharmacotherapy.

Publications per year

1998–2015

Publications

Reduced expression of the <i>Kinesin-Associated Protein 3</i> ( <i>KIFAP3</i> ) gene increases survival in sporadic amyotrophic lateral sclerosis

John E. Landers, Judith Melki, Vincent Meininger et al. · Proceedings of the National Academy of Sciences · 2009 · 185 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse

Sylvie Braschi, Nicole Couture, A. Gambarotta et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1998 · 31 citations

Life Sciences, Biochemistry, Enzymology +13

A Phase II Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVD lite) for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

Elizabeth O’Donnell, Jacob P. Laubach, Andrew J. Yee et al. · Blood · 2014 · 17 citations

Medicine, Oncology, Pharmacotherapy +17

A Phase I/II Open-Label Multicenter Study Of The Cyclin Kinase Inhibitor AT7519M Alone and In Combination With Bortezomib In Patients With Previously Treated Multiple Myeloma

Noopur Raje, Parameswaran Hari, Heather Landau et al. · Blood · 2013 · 16 citations

Medicine, Oncology, Pharmacology +16

A Phase II Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVD-lite) for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

Elizabeth O’Donnell, Jacob P. Laubach, Andrew J. Yee et al. · Blood · 2015 · 11 citations

Medicine, Oncology, Pharmacotherapy +16

1–5 of 6